Natural Life Nutrition Inc.   Report issue

For profit Phase 2
Founded: Burnaby Canada (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2018
NCT03769285
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Natural Life Nutrition

Active Ingredients

Drugs in Phase 2 Trials (1)

nicotinamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Skin Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1